Ultragenyx Pharmaceutical | RARE - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $12.26M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 1.67M 746K
Agios Pharmaceuticals AGIO:US USD 554K 141K
Alnylam Pharmaceuticals ALNY:US USD 54.87M 3.6M
BioCryst Pharmaceuticals BCRX:US USD 938K 1.56M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bluebird Bio BLUE:US USD 3.38M 3.36M
Esperion Therapeutics ESPR:US USD 11.65M 7.49M
Insmed INSM:US USD 13.83M 761K
Ionis Pharmaceuticals IONS:US USD 1.34M 2.34M
Karyopharm Therapeutics KPTI:US USD 1.35M 517K
Kyowa Hakko Kirin 4151:JP JPY 18.95B 3.82B
MacroGenics MGNX:US USD 3.52M 1.73M
Mirati Therapeutics MRTX:US 817K 217K
Moderna Inc MRNA:US USD 792M 1.13B
Neurocrine Biosciences NBIX:US USD 8.5M 800K
PTC Therapeutics PTCT:US USD 14.14M 3.25M
Puma Biotechnology PBYI:US USD 13.22M 3.62M
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Sarepta Therapeutics SRPT:US USD 35.02M 4.22M
Ultragenyx Pharmaceutical RARE:US USD 12.26M 6.94M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M